Search results
Results from the WOW.Com Content Network
The 2010 Johnson & Johnson children's product recall involved 43 over-the-counter children's medicines announced by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, on April 30, 2010. Medications in the recall included liquid versions of Tylenol, Tylenol Plus, Motrin, Zyrtec, and Benadryl. The products were recalled after it was ...
Johnson and Johnson's McNeil Consumer Healthcare has expanded its recall of its popular over-the-counter drugs Tylenol, Benadryl and Motrin because of a foul odor. Consumers who bought these lots ...
Diversion, abuse, and a relatively high rate of overdose deaths in comparison to other drugs of its group. This drug continues to be available in most of the world including the US, but under strict controls. Terfenadine (Seldane, Triludan) 1997–1998 France, South Africa, Oman, others, US Prolonged QT interval; ventricular tachycardia [2] [3]
The Food and Drug Administration is reportedly investigating reports of at least 775 serious side effects from drugs recalled by McNeil Consumer Healthcare, a division of Johnson & Johnson.
A House committee hearing concerning Johnson & Johnson's (JNJ) recall of children's medicine -- the largest in the history of the U.S. Food and Drug Administration -- began Thursday morning. Last ...
On April 30, 2010, another recall was issued for 40 products including liquid infant and children's pain relievers Tylenol and Motrin, and allergy medications Zyrtec and Benadryl. [19] An FDA report said its inspectors found thick dust and grime covering certain equipment, a hole in the ceiling, and duct tape-covered pipes at the Fort ...
Perfect Recall Johnson & Johnson has survived recalls before, of course, most notably the 1982 fiasco when seven people in the Chicago area died after taking Extra Strength Tylenol capsules that ...
Trademarked in 1918, Anacin is one of the oldest brands of pain relievers in the United States. It originally contained acetophenetidin (phenacetin) and was promoted as "aspirin-free relief," but was reformulated in the 1980s following the FDA's ruling to withdraw phenacetin from the market in 1983 due to concerns over its carcinogenic properties.